249 related articles for article (PubMed ID: 24465502)
1. CD4+ primary T cells expressing HCV-core protein upregulate Foxp3 and IL-10, suppressing CD4 and CD8 T cells.
Fernandez-Ponce C; Dominguez-Villar M; Aguado E; Garcia-Cozar F
PLoS One; 2014; 9(1):e85191. PubMed ID: 24465502
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of FOXP3 and induction of suppressive function in CD4+ Jurkat T-cells expressing hepatitis C virus core protein.
Dominguez-Villar M; Fernandez-Ponce C; Munoz-Suano A; Gomez E; Rodríguez-Iglesias M; Garcia-Cozar F
Clin Sci (Lond); 2012 Jul; 123(1):15-27. PubMed ID: 22214248
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients.
Zhai N; Chi X; Li T; Song H; Li H; Jin X; Crispe IN; Su L; Niu J; Tu Z
Cell Mol Immunol; 2015 Nov; 12(6):743-9. PubMed ID: 25531392
[TBL] [Abstract][Full Text] [Related]
4. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection.
Cabrera R; Tu Z; Xu Y; Firpi RJ; Rosen HR; Liu C; Nelson DR
Hepatology; 2004 Nov; 40(5):1062-71. PubMed ID: 15486925
[TBL] [Abstract][Full Text] [Related]
5. HCV-infected hepatocytes drive CD4+ CD25+ Foxp3+ regulatory T-cell development through the Tim-3/Gal-9 pathway.
Ji XJ; Ma CJ; Wang JM; Wu XY; Niki T; Hirashima M; Moorman JP; Yao ZQ
Eur J Immunol; 2013 Feb; 43(2):458-67. PubMed ID: 23161469
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway.
Ren JP; Zhao J; Dai J; Griffin JW; Wang L; Wu XY; Morrison ZD; Li GY; El Gazzar M; Ning SB; Moorman JP; Yao ZQ
Immunology; 2016 Aug; 148(4):377-86. PubMed ID: 27149428
[TBL] [Abstract][Full Text] [Related]
7. Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.
Scholzen A; Mittag D; Rogerson SJ; Cooke BM; Plebanski M
PLoS Pathog; 2009 Aug; 5(8):e1000543. PubMed ID: 19680449
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus core protein reduces CD8
Khan ST; Karges W; Cooper CL; Crawley AM
Immunology; 2018 May; 154(1):156-165. PubMed ID: 29266204
[TBL] [Abstract][Full Text] [Related]
9. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.
Wedemeyer H; He XS; Nascimbeni M; Davis AR; Greenberg HB; Hoofnagle JH; Liang TJ; Alter H; Rehermann B
J Immunol; 2002 Sep; 169(6):3447-58. PubMed ID: 12218168
[TBL] [Abstract][Full Text] [Related]
10. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.
Boettler T; Spangenberg HC; Neumann-Haefelin C; Panther E; Urbani S; Ferrari C; Blum HE; von Weizsäcker F; Thimme R
J Virol; 2005 Jun; 79(12):7860-7. PubMed ID: 15919940
[TBL] [Abstract][Full Text] [Related]
11. F protein increases CD4+CD25+ T cell population in patients with chronic hepatitis C.
Hashempour T; Bamdad T; Bergamini A; Lavergne JP; Haj-Sheykholeslami A; Brakier-Gingras L; Ajorloo M; Merat S
Pathog Dis; 2015 Jun; 73(4):. PubMed ID: 25862675
[TBL] [Abstract][Full Text] [Related]
12. Expression of programmed cell death protein 1 and T-cell immunoglobulin- and mucin-domain-containing molecule-3 on peripheral blood CD4+CD8+ double positive T cells in patients with chronic hepatitis C virus infection and in subjects who spontaneously cleared the virus.
Caraballo Cortés K; Osuch S; Perlejewski K; Pawełczyk A; Kaźmierczak J; Janiak M; Jabłońska J; Nazzal K; Stelmaszczyk-Emmel A; Berak H; Bukowska-Ośko I; Paciorek M; Laskus T; Radkowski M
J Viral Hepat; 2019 Aug; 26(8):942-950. PubMed ID: 30972915
[TBL] [Abstract][Full Text] [Related]
13. Lymphotropic HCV strain can infect human primary naïve CD4+ cells and affect their proliferation and IFN-γ secretion activity.
Kondo Y; Ueno Y; Kakazu E; Kobayashi K; Shiina M; Tamai K; Machida K; Inoue J; Wakui Y; Fukushima K; Obara N; Kimura O; Shimosegawa T
J Gastroenterol; 2011 Feb; 46(2):232-41. PubMed ID: 20714907
[TBL] [Abstract][Full Text] [Related]
14. IL-15 acts as a potent inducer of CD4(+)CD25(hi) cells expressing FOXP3.
Imamichi H; Sereti I; Lane HC
Eur J Immunol; 2008 Jun; 38(6):1621-30. PubMed ID: 18493981
[TBL] [Abstract][Full Text] [Related]
15. Decreased suppression of CD8
Giri PS; Dwivedi M; Begum R
Exp Dermatol; 2020 Aug; 29(8):759-775. PubMed ID: 32682346
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic and functional alterations of primary human PBMCs induced by HCV non-enveloped capsid-like particles uptake.
Doumba PP; Serti E; Boutsikou M; Konstadoulakis MM; Georgopoulou U; Koskinas J
Cell Mol Life Sci; 2013 Sep; 70(18):3463-74. PubMed ID: 23645326
[TBL] [Abstract][Full Text] [Related]
17. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
Chi PD; Li L; Fan YY; Wu CY
Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-7 promotes human regulatory T cell development at the CD4+CD8+ double-positive thymocyte stage.
Tuulasvaara A; Vanhanen R; Baldauf HM; Puntila J; Arstila TP
J Leukoc Biol; 2016 Sep; 100(3):491-8. PubMed ID: 26965634
[TBL] [Abstract][Full Text] [Related]
19. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
[TBL] [Abstract][Full Text] [Related]
20. Quantification of hepatic FOXP3+ T-lymphocytes in HIV/hepatitis C coinfection.
Williams SK; Donaldson E; Van der Kleij T; Dixon L; Fisher M; Tibble J; Gilleece Y; Klenerman P; Banham AH; Howard M; Webster DP
J Viral Hepat; 2014 Apr; 21(4):251-9. PubMed ID: 24597693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
